Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: Detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting
2 dimensional; 2D; 3 dimensional cardiac magnetic resonance; 3D CMR; CAD; coronary artery disease; DE; delayed enhancement; echo time; k space and time; k t; left ventricle ventricular; LV; repetition time; TE; TR; volume of myocardial hypoenhancement; VOLUMEhypo
Indexed keywords
ADENOSINE;
GADOLINIUM PENTETATE;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CARDIAC MAGNETIC RESONANCE PERFUSION IMAGING;
CINEANGIOCARDIOGRAPHY;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC TEST ACCURACY STUDY;
FEMALE;
HEART LEFT VENTRICLE VOLUME;
HEART MUSCLE PERFUSION;
HUMAN;
IMAGE QUALITY;
MAJOR CLINICAL STUDY;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUCLEAR MAGNETIC RESONANCE SCANNER;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
STRESS RADIOGRAPHY;
THREE DIMENSIONAL IMAGING;
VOLUMETRY;
Optimizing spatiotemporal sampling for k-t BLAST and k-t SENSE: Application to high-resolution real-time cardiac steady-state free precession
J. Tsao, S. Kozerke, P. Boesiger, and K.P. Pruessmann Optimizing spatiotemporal sampling for k-t BLAST and k-t SENSE: application to high-resolution real-time cardiac steady-state free precession Magn Reson Med 53 2005 1372 1382
K-t BLAST and k-t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlations
J. Tsao, P. Boesiger, and K.P. Pruessmann k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations Magn Reson Med 50 2003 1031 1042
High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease
S. Plein, S. Kozerke, and D. Suerder High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease Eur Heart J 29 2008 2148 2155
Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense
S. Plein, S. Ryf, J. Schwitter, A. Radjenovic, P. Boesiger, and S. Kozerke Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense Magn Reson Med 58 2007 777 785
WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy
R.J. Ogg, P.B. Kingsley, and J.S. Taylor WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy J Magn Reson B 104 1994 1 10
Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease
R. Gebker, C. Jahnke, and I. Paetsch Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease Radiology 247 2008 57 63
MR-IMPACT: Comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
J. Schwitter, C.M. Wacker, and A.C. van Rossum MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Eur Heart J 29 2008 480 489
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging
S.E. Petersen, M. Jerosch-Herold, and L.E. Hudsmith Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging Circulation 115 2007 2418 2425
Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis
D.S. Berman, X. Kang, and H. Gransar Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis J Nucl Cardiol 16 2009 45 53
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
L.J. Shaw, D.S. Berman, and D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291